Companies Incubator San Diego Seed Funding 
socalTECH
JUNE 13, 2019
San Diego-based Atlazo , a startup developing systems-on-a-chip (SoC) semiconductors aimed at used in healthcare and Internet-of-Things (IoT) applications, has raised $3.4M in a seed funding round. The funding round was led by the Tech Coast Angels, and the TCA's San Diego chapter. in the round.
socalTECH
FEBRUARY 5, 2021
San Diego-based Launch Factory a new "venture studio" which is looking to recruit entrepeneurs to help it launch vetted business concepts, recently raised $2.5M in funding, according to the group. The funding came from a number of angels, including Broadway Angels, San Diego Venture Partners, and TI Platform Management.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
MAY 27, 2015
La Jollla-based MANTA Instruments , a developer of technology for characterizing nanoparticles, has raised a round of seed funding, from Triton Technology Fund. Size of the funding was not announced. The company is part of the EvoNexus startup incubator, and is led by Rick Cooper.
socalTECH
APRIL 8, 2014
Among those funds is TYLT Lab (www.tyltlab.com), which recently announced a new, $20M early stage investment fund specifically focused on companies here. We''re pretty agnostic in terms of the kind of company, and historically we''ve been all over the place. Pretty much the top four carriers here.
Tech Zulu Event
OCTOBER 26, 2011
Entrepreneurs in Los Angeles, San Diego and the Orange County with innovative ideas, particularly in the social, mobile, local media and Internet marketplaces, can apply for the opportunity to be a part of this emerging community. SoCal is home to some of the greatest startup success stories.
Tech Zulu Event
OCTOBER 26, 2011
Entrepreneurs in Los Angeles, San Diego and the Orange County with innovative ideas, particularly in the social, mobile, local media and Internet marketplaces, can apply for the opportunity to be a part of this emerging community. SoCal is home to some of the greatest startup success stories.
Xconomy
JUNE 3, 2016
billion acquisition of San Diego’s Auspex Pharmaceuticals last year. A company official told Xconomy the drug would be priced in line with standard of care enzyme replacement therapy, which costs around $300,000 per patient, per year. . Teva nabbed deutetrabenazine in its $3.2
Expert insights. Personalized for you.
124 
Let's personalize your content